Crysvita (Burosumab shortage status
1 active shortage notice across 1 country.
Last updated 1 Nov 2026 · sourced from official medicines regulators
- Generic name (INN)
- Crysvita (Burosumab
- Class
- Auto-created by Health Canada — Recalls and Safety Alerts scraper
Where Crysvita (Burosumab is in shortage
Why Crysvita (Burosumab is in shortage
- causes not stated by the regulator — e.g. “Risk of severe hypercalcaemia 2” (Malaysia)
Frequently asked questions
Is Crysvita (Burosumab currently in shortage?
Yes. As of the latest regulator updates, Crysvita (Burosumab has 1 active shortage notice across 1 country (Malaysia). Status is refreshed daily from official regulatory sources.
Why is Crysvita (Burosumab in shortage?
Regulators attribute the current Crysvita (Burosumab shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Crysvita (Burosumab shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Crysvita (Burosumab status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.